Malignant tumour incidence rate in Latvia and in the world grows year on year. Depending on localisation, hereditary tumours account for 5-30% of consecutive cancer patients.
Timely molecular genetic testing enables understanding the disease and allows forecast its emergence and chose treatment strategy. With this test you can protect yourself and your loved ones, because if changes in genes that increase cancer risks are detected before they have developed, it is possible to do a timely risk assessment and chose the right diagnosis and risk mitigation options. If any changes in the genes that increase risk of cancer are identified, we recommend informing your family who can have the same mutation because they would also need testing to establish their risks. For ethical reasons, molecular genetic testing of underage children is done only in the event of specific hereditary tumour syndromes when tumour development is possible before the child reaches the age of majority.
iVF Riga Genetics Centre offers genetic testing for hereditary tumours
iVF Riga Genetics Centre offers its patients genetic testing both for predicting risk of a specific hereditary cancer and to rule out the most common mutations in healthy people.
iVF Riga Genetics Centre also offers genetic consultations after testing to answer any additional questions about hereditary tumour development risks and necessary family genetic consultation.
For more information visit iVF Riga Genetics Centre website: https://genetikascentrs.lv/pakalpojumi/parmantoto-audzeju-genetiska-testesana/.
Call us (Working hours 09:00 - 17:00)(+371) 67 111 117 (+371) 25 641 022
Write to firstname.lastname@example.org